UK markets open in 2 hours 35 minutes
NIKKEI 225
37,163.76 -915.94 (-2.41%) HANG SENG
16,184.02 -201.85 (-1.23%) CRUDE OIL
84.73 +2.00 (+2.42%) GOLD FUTURES
2,403.50 +5.50 (+0.23%) DOW
37,775.38 +22.07 (+0.06%) Bitcoin GBP
50,116.91 +367.73 (+0.74%)
Blueprint Medicines Corporation (BPMC)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 5.44B |
| Enterprise value | 5.06B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 21.58 |
| Price/book (mrq) | 41.67 |
| Enterprise value/revenue | 20.31 |
| Enterprise value/EBITDA | -10.77 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.65 |
| 52-week change 3 | 81.24% |
| S&P500 52-week change 3 | 21.23% |
| 52-week high 3 | 101.00 |
| 52-week low 3 | 43.89 |
| 50-day moving average 3 | 88.78 |
| 200-day moving average 3 | 69.41 |
Share statistics
| Avg vol (3-month) 3 | 777.58k |
| Avg vol (10-day) 3 | 547.1k |
| Shares outstanding 5 | 61.23M |
| Implied shares outstanding 6 | 61.23M |
| Float 8 | 60.55M |
| % held by insiders 1 | 0.85% |
| % held by institutions 1 | 108.13% |
| Shares short (28 Mar 2024) 4 | 4.37M |
| Short ratio (28 Mar 2024) 4 | 5.37 |
| Short % of float (28 Mar 2024) 4 | 9.60% |
| Short % of shares outstanding (28 Mar 2024) 4 | 7.14% |
| Shares short (prior month 29 Feb 2024) 4 | 5.14M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -203.30% |
| Operating margin (ttm) | -146.07% |
Management effectiveness
| Return on assets (ttm) | -25.34% |
| Return on equity (ttm) | -157.13% |
Income statement
| Revenue (ttm) | 249.38M |
| Revenue per share (ttm) | 4.12 |
| Quarterly revenue growth (yoy) | 85.50% |
| Gross profit (ttm) | N/A |
| EBITDA | -474.61M |
| Net income avi to common (ttm) | -506.98M |
| Diluted EPS (ttm) | -8.37 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 710.64M |
| Total cash per share (mrq) | 11.61 |
| Total debt (mrq) | 774.12M |
| Total debt/equity (mrq) | 592.70% |
| Current ratio (mrq) | 3.76 |
| Book value per share (mrq) | 2.14 |
Cash flow statement
| Operating cash flow (ttm) | -436.85M |
| Levered free cash flow (ttm) | -239.41M |
© 2024 Yahoo. All rights reserved.